全文获取类型
收费全文 | 22535篇 |
免费 | 3033篇 |
国内免费 | 797篇 |
专业分类
耳鼻咽喉 | 64篇 |
儿科学 | 334篇 |
妇产科学 | 170篇 |
基础医学 | 1583篇 |
口腔科学 | 279篇 |
临床医学 | 1665篇 |
内科学 | 2627篇 |
皮肤病学 | 164篇 |
神经病学 | 853篇 |
特种医学 | 381篇 |
外国民族医学 | 2篇 |
外科学 | 987篇 |
综合类 | 2013篇 |
一般理论 | 3篇 |
预防医学 | 2954篇 |
眼科学 | 236篇 |
药学 | 9546篇 |
3篇 | |
中国医学 | 1472篇 |
肿瘤学 | 1029篇 |
出版年
2023年 | 323篇 |
2022年 | 334篇 |
2021年 | 631篇 |
2020年 | 734篇 |
2019年 | 811篇 |
2018年 | 771篇 |
2017年 | 798篇 |
2016年 | 796篇 |
2015年 | 836篇 |
2014年 | 1167篇 |
2013年 | 1925篇 |
2012年 | 1326篇 |
2011年 | 1365篇 |
2010年 | 1019篇 |
2009年 | 1082篇 |
2008年 | 1117篇 |
2007年 | 1207篇 |
2006年 | 1110篇 |
2005年 | 972篇 |
2004年 | 838篇 |
2003年 | 674篇 |
2002年 | 581篇 |
2001年 | 567篇 |
2000年 | 480篇 |
1999年 | 437篇 |
1998年 | 364篇 |
1997年 | 353篇 |
1996年 | 349篇 |
1995年 | 336篇 |
1994年 | 276篇 |
1993年 | 275篇 |
1992年 | 272篇 |
1991年 | 230篇 |
1990年 | 226篇 |
1989年 | 185篇 |
1988年 | 196篇 |
1987年 | 183篇 |
1986年 | 184篇 |
1985年 | 145篇 |
1984年 | 142篇 |
1983年 | 63篇 |
1982年 | 111篇 |
1981年 | 114篇 |
1980年 | 96篇 |
1979年 | 80篇 |
1978年 | 64篇 |
1977年 | 60篇 |
1976年 | 39篇 |
1975年 | 37篇 |
1974年 | 23篇 |
排序方式: 共有10000条查询结果,搜索用时 203 毫秒
91.
目的 探讨健康支持性环境中的不同特征变量对四川省农村人群的不同血压水平的影响。方法 采用多阶段整群抽样的方法,随机抽取四川省7个县(区)8400名的18岁以上常住居民为调查对象。问卷调查一般人口学特征、身体活动行为特征和环境等信息。采用标准方法测量身高、体重、腰围和血压。采用无序多分类logistic回归分析。结果 本调查人群中共检出正常高值血压者4270例,检出率为50.83%,标化率为37.02%,平均年龄(56.22±14.89)岁;高血压患者1498例,检出率为17.83%,标化率为7.92%,平均年龄(65.26±11.28)岁。无序多分类logistic回归结果显示,住宿环境好、获得运动方面的健康信息和参与中等强度活动150Symbol~A@300min/周是正常高值血压和高血压人群的共同保护因素;住宿便利(OR=0.789, 95%CI:0.649~0.958, P=0.017)、医疗服务可及性便利(OR=0.686, 95%CI:0.509~0.924, P=0.013)、对健身步道和健身广场满意为高血压人群的保护因素。结论 多途径合理构建健康支持性环境,对农村正常高值血压者和高血压患者具有保护作用,对遏制农村高血压的流行现状起到一定作用。 相似文献
92.
Xiaoxv Dong Yawen Zeng Yi Liu Longtai You Xingbin Yin Jing Fu Jian Ni 《Phytotherapy research : PTR》2020,34(2):270-281
Aloe‐emodin is a naturally anthraquinone derivative and an active ingredient of Chinese herbs, such as Cassia occidentalis, Rheum palmatum L., Aloe vera, and Polygonum multiflorum Thunb. Emerging evidence suggests that aloe‐emodin exhibits many pharmacological effects, including anticancer, antivirus, anti‐inflammatory, antibacterial, antiparasitic, neuroprotective, and hepatoprotective activities. These pharmacological properties lay the foundation for the treatment of various diseases, including influenza virus, inflammation, sepsis, Alzheimer's disease, glaucoma, malaria, liver fibrosis, psoriasis, Type 2 diabetes, growth disorders, and several types of cancers. However, an increasing number of published studies have reported adverse effects of aloe‐emodin. The primary toxicity among these reports is hepatotoxicity and nephrotoxicity, which are of wide concern worldwide. Pharmacokinetic studies have demonstrated that aloe‐emodin has a poor intestinal absorption, short elimination half‐life, and low bioavailability. This review aims to provide a comprehensive summary of the pharmacology, toxicity, and pharmacokinetics of aloe‐emodin reported to date with an emphasis on its biological properties and mechanisms of action. 相似文献
93.
《Radiologia》2022,64(3):256-265
Breast cancer is the second most common cancer in Peruvian women. Due to limitations in national breast cancer screening programs, especially in rural areas, more than 50% of cases of breast cancer in Peru are diagnosed in advanced stages. In collaboration with a local clinic registered as a nongovernmental organization (CerviCusco), RAD-AID International aims to create a sustainable diagnostic structure to improve breast cancer screening in Cuzco. With the support of local, national, and international partners that have collaborated in analyzing radiological resources, raising awareness in the population, acquiring equipment, training clinical staff, and building referral networks, our teams of radiologists, included in the RAD-AID team, have participated in training CerviCusco staff in breast ultrasound, thus enabling additional training for radiology residents through a regulated international collaboration. 相似文献
94.
95.
ObjectiveTo analyze the nutritional status (NS) of patients older than 65 years and establish their relationship with sociodemographic and health variables.DesignCross-sectional observational study in patients older than 65 years.Location3 health centers.Participants255 patients: ambulatory (AP), in domiciliary care (DP) or institutionalized (IP). They completed the study 243 (response rate 95.3%).Main measurementsThe Chang method was applied to determine the NS. Sociodemographic, anthropometric variables, dependence, mood, cognitive and analytical parameters were collected. Associations were analyzed applying chi-square and analysis of variance. The prevalence ratio (PR) for malnutrition was calculated. A multivariate model was applied (binary logistic regression). Significance was considered for p<0.05.ResultsThe average age was 81.3 years (SD = 7.4) and 72.0% were women. 48.9% were AP, 26.8% DP and 24.2% IP. 29.6% (95% CI: 23.9-35.8) presented malnutrition. Greater malnutrition was established in relation to living in a residence or requiring home help (PR = 5.3), age over 85 (PR = 4.9), presenting a moderate or higher dependency for basic activities of daily living (PR = 3.9) and instrumental (PR = 3.3), need help for mobility (PR = 2.9) and present moderate/severe cognitive impairment (PR = 2.1). The determinants of malnutrition in the multivariate model were older than 85 years old and being IP or DP.ConclusionsEmphasis should be placed on evaluating NS in patients older than 85 years of age who live in a residence or require home care, since they are the groups at greatest risk of malnutrition. 相似文献
96.
《Health & place》2016
This study examines the availability and use of neighborhood resources in relation to clinical lower limb osteoarthritis (LLOA) in older participants from six European countries. Of the 2757 participants (65–85 years), 22.7% had LLOA. Participants with LLOA made more use of places to sit (OR=2.50; CI: 1.36–4.60 in the UK), and less use of parks and walking areas (OR=0.30; CI: 0.12–0.75 in Sweden), compared to participants without LLOA, particularly in countries with high availability of resources. The results suggest that specific features of the environment impact the use of neighborhood resources by older adults with LLOA. 相似文献
97.
E. Niclas Jonsson Rujia Xie Scott F. Marshall Rosalin H. Arends 《British journal of clinical pharmacology》2016,81(4):688-699
AimsThe aims were to 1) develop the pharmacokinetics model to describe and predict observed tanezumab concentrations over time, 2) test possible covariate parameter relationships that could influence clearance and distribution and 3) assess the impact of fixed dosing vs. a dosing regimen adjusted by body weight.MethodsIndividual concentration–time data were determined from 1608 patients in four phase 3 studies conducted to assess efficacy and safety of intravenous tanezumab. Patients received two or three intravenous doses (2.5, 5 or 10 mg) every 8 weeks. Blood samples for assessment of tanezumab PK were collected at baseline, 1 h post‐dose and at weeks 4, 8, 16 and 24 (or early termination) in all studies. Blood samples were collected at week 32 in two studies. Plasma samples were analyzed using a sensitive, specific, validated enzyme‐linked immunosorbent assay.ResultsA two compartment model with parallel linear and non‐linear elimination processes adequately described the data. Population estimates for clearance (CL), central volume (V
1), peripheral volume (V
2), inter‐compartmental clearance, maximum elimination capacity (VM) and concentration at half‐maximum elimination capacity were 0.135 l day–1, 2.71 l, 1.98 l, 0.371 l day–1, 8.03 μg day–1 and 27.7 ng ml–1, respectively. Inter‐individual variability (IIV) was included on CL, V
1, V
2 and VM. A mixture model accounted for the distribution of residual error. While gender, dose and creatinine clearance were significant covariates, only body weight as a covariate of CL, V
1 and V
2 significantly reduced IIV.ConclusionsThe small increase in variability associated with fixed dosing is consistent with other monoclonal antibodies and does not change risk : benefit. 相似文献
98.
Trastuzumab, a key treatment for HER2-positive breast cancer, is available in weight-based IV and fixed-dose (600 mg) SC formulations. While the Phase 3 HannaH trial indicated non-inferiority of the SC formulation, there is some concern that the target plasma concentration may not be reached in overweight/obese patients whereas low-body-weight patients may be at risk of toxicity.This scoping review evaluated whether overweight/obese patients are at risk of below-target exposure with fixed-dose SC trastuzumab, whether low-body-weight patients are at risk of increased toxicity, especially cardiotoxicity, and whether IV and SC trastuzumab are equivalent in terms of treatment-emergent adverse events (TEAEs) (e.g. infections). Thirty-seven publications that met the eligibility criteria were included.Body weight is not an important determinant of exposure to trastuzumab at steady state (i.e. pre-dose cycle 8); however, real-world evidence suggests that the target concentration (20 μg/mL) may not be reached with the first SC dose in overweight/obese patients. There is no evidence that low-body-weight patients are at increased risk of cardiotoxicity with SC trastuzumab, although this may be confounded by the higher rate of cardiovascular comorbidities in overweight patients. In Phase 3 trials, SC trastuzumab was associated with higher rates of ISRs, ADAs and SAEs, the latter often requiring hospitalization and occurring during adjuvant treatment when patients are not burdened by chemotherapy.The route of administration of trastuzumab (IV vs SC) in different treatment settings should be discussed with the patient, taking into account the risks and benefits associated with each route. 相似文献
99.
Alexander Ayala Kyle Tegtmeyer Giancarlo Atassi Elizabeth Powell 《The Journal of emergency medicine》2021,60(5):661-668
BackgroundProlonged emergency department (ED) wait times could potentially lead to increased morbidity and mortality. While previous work has demonstrated disparities in wait times associated with race, information about the relationship between experiencing homelessness and ED wait times is lacking.ObjectivesThe purpose of this study was to explore the relationship between residence status (undomiciled vs. domiciled) and ED wait times. We hypothesized that being undomiciled would be associated with longer wait times.MethodsWe obtained data from the National Hospital Ambulatory Medical Care Survey from 2014 to 2017. We compared wait times in each triage category using t tests. We used multivariate linear regression to explore associations between residence status and wait times while controlling for other patient- and hospital-level variables.ResultsOn average, undomiciled patients experienced significantly longer mean ED wait times than domiciled patients (53.4 vs. 38.9 min; p < 0.0001). In the multivariate model, undomiciled patients experienced significantly different wait times by 15.5 min (p = 0.0002). Undomiciled patients experienced increasingly longer waits vs. domiciled patients for the emergent and urgent triage categories (+33.5 min, p < 0.0001, and +22.7 min, p < 0.0001, respectively).ConclusionsUndomiciled patients experience longer ED wait times when compared with domiciled patients. This disparity is not explained by undomiciled patients seeking care in the ED for minor illness, because the disparity is more pronounced for urgent and emergent triage categories. 相似文献
100.